Patent Assignment
Reel/Frame 061367/0674
Security Interest
Recorded: 2022-10-10
Pages: 11
Assignor
PHASEBIO PHARMACEUTICALS, INC.
Executed: 2022-10-07
Assignee
JMB CAPITAL PARTNERS LENDING, LLC
205 SOUTH MARTEL AVENUE, LOS ANGELES, CALIFORNIA, 90036
Covered Properties
(22)
Multimeric Elp Fusion Constructs
Modified Vasoactive Intestinal Peptides
Formulations of Active Agents for Sustained Release
Application:
14/099,590 →
Publication:
US 2014/0171370
Use of Modified Vasoactive Intestinal Peptides in the Treatment of Hypertension
Modified Vasoactive Intestinal Peptides
Use of Modified Vasoactive Intestinal Peptides in the Treatment of Hypertension
Methods and Compositions for Treating Cystic Fibrosis
A Method for Administering a Sustained Release Formulation
Elp Fusion Proteins for Controlled and Sustained Release
Methods and Compositions for Treating Muscle Disease and Disorders
Modified Vasoactive Intestinal Peptides
Application:
15/621,320 →
Publication:
US 2018/0008677
Metalloenzyme Inhibitor Compounds
Elp Fusion Proteins for Controlled and Sustained Release
Application:
16/099,261 →
Publication:
US 2019/0218274
Metalloenzyme Inhibitor Compounds
Metalloenzyme Inhibitor Compounds
Methods and Compositions for Treating Cystic Fibrosis
Application:
17/365,443 →
Publication:
US 2022/0023390
Metalloenzyme Inhibitor Compounds
Metalloenzyme Inhibitor Compounds
Methods and Compositions for Treating Muscle Disease and Disorders
Application:
17/583,883 →
Publication:
US 2022/0288170
Elp Fusion Proteins Comprising Parathyroid Hormone for Controlled and Sustained Release
Application:
17/633,369 →
Publication:
US 2022/0289812
Pharmacokinetic & Pharmacodynamic Model for Determining Effective Dose of Anti-Ticagrelor Antibody
Application:
17/739,491 →
Publication:
US 2023/0192895
Elp Fusion Proteins Comprising Parathyroid Hormone for Controlled and Sustained Release
Application:
62/884,792 →
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Jan 23, 2007
From: DAGHER, SUZANNE
To: PHASE BIOSCIENCE, INC.
Reel/Frame 018802/0961 →
Change of Name
Mar 26, 2010
From: PHASE BIOSCIENCE, INC.
To: PHASEBIO PHARMACEUTICALS, INC.
Reel/Frame 024143/0049 →
Assignment of Assignor's Interest
Jun 30, 2011
From: SADEGHI, HOMAYOUN; TURNER, ANDREW; DAGHER, SUZANNE
To: PHASBIO PHARMACEUTICALS, INC.
Reel/Frame 026530/0468 →
Assignment of Assignor's Interest
Mar 10, 2014
From: GEORGOPOULOS, LYNNE M.; ARNOLD, SUSAN
To: PHASEBIO PHARMACEUTICALS, INC.
Reel/Frame 032388/0090 →
Assignment of Assignor's Interest
Mar 10, 2014
From: ARNOLD, SUSAN; PRIOR, CHRISTOPHER
To: PHASEBIO PHARMACEUTICALS, INC.
Reel/Frame 032388/0075 →
Assignment of Assignor's Interest
Nov 23, 2015
From: SADEGHI, HOMAYOUN; DAGHER, SUZANNE; TURNER, ANDREW
To: PHASEBIO PHARMACEUTICALS, INC.
Reel/Frame 037117/0277 →
Assignment of Assignor's Interest
Feb 1, 2018
From: ARNOLD, SUSAN; PRIOR, CHRISTOPHER; GEORGOPOULOS, LYNNE
To: PHASEBIO PHARMACEUTICALS, INC.
Reel/Frame 044795/0680 →
Assignment of Assignor's Interest
Feb 13, 2018
From: VIAMET PHARMACEUTICALS (NC), INC.
To: VIAMET PHARMACEUTICALS (BERMUDA), LTD.
Reel/Frame 044910/0123 →
Assignment of Assignor's Interest
Feb 13, 2018
From: SPARKS, STEVEN; YATES, CHRISTOPHER M.; SHAVER, SAMMY R.; HOEKSTRA, WILLIAM J.
To: VIAMET PHARMACEUTICALS (NC), INC.
Reel/Frame 044910/0053 →
Assignment of Assignor's Interest
Apr 4, 2018
From: ARNOLD, SUSAN; BALLANCE, DAVID JAMES
To: PHASEBIO PHARMACEUTICALS, INC.
Reel/Frame 045434/0757 →
Assignment of Assignor's Interest
Jun 15, 2018
From: GEORGOPOULOS, LYNNE M.; ARNOLD, SUSAN
To: PHASEBIO PHARMACEUTICALS, INC.
Reel/Frame 046099/0507 →
Assignment of Assignor's Interest
Jun 15, 2018
From: SADEGHI, HOMAYOUN; DAGHER, SUZANNE; TURNER, ANDREW
To: PHASEBIO PHARMACEUTICALS, INC.
Reel/Frame 046097/0317 →
Change of Name
Dec 21, 2018
From: VIAMET PHARMACEUTICALS (BERMUDA), LTD.
To: SELENITY THERAPEUTICS (BERMUDA), LTD.
Reel/Frame 047978/0274 →
Assignment of Assignor's Interest
Apr 4, 2019
From: JOWETT, JAMES; BALLANCE, DAVID JAMES
To: PHASEBIO PHARMACEUTICALS, INC.
Reel/Frame 048796/0907 →
Assignment of Assignor's Interest
Apr 18, 2019
From: VIAMET PHARMACEUTICALS (NC), INC.
To: VIAMET PHARMACEUTICALS (BERMUDA), LTD.
Reel/Frame 048930/0527 →
Assignment of Assignor's Interest
Apr 18, 2019
From: SPARKS, STEVEN; YATES, CHRISTOPHER M.; SHAVER, SAMMY R.; HOEKSTRA, WILLIAM J.
To: VIAMET PHARMACEUTICALS (NC), INC.
Reel/Frame 048930/0474 →
Change of Name
May 2, 2019
From: VIAMET PHARMACEUTICALS (BERMUDA), LTD.
To: SELENITY THERAPEUTICS (BERMUDA), LTD.
Reel/Frame 049074/0397 →
Assignment of Assignor's Interest
Jan 2, 2020
From: GEORGOPOULOS, LYNNE; ARNOLD, SUSAN; BALLANCE, DAVID JAMES
To: PHASEBIO PHARMACEUTICALS, INC.
Reel/Frame 051401/0327 →
Assignment of Assignor's Interest
Feb 20, 2020
From: JOWETT, JAMES; BALLANCE, DAVID JAMES
To: PHASEBIO PHARMACEUTICALS, INC.
Reel/Frame 051871/0800 →
Assignment of Assignor's Interest
Feb 20, 2020
From: JOWETT, JAMES; BALLANCE, DAVID JAMES
To: PHASEBIO PHARMACEUTICALS, INC.
Reel/Frame 051871/0854 →
Assignment of Assignor's Interest
Feb 20, 2020
From: SELENITY THERAPEUTICS (BERMUDA), LTD.
To: PHASEBIO PHARMACEUTICALS, INC.
Reel/Frame 051878/0894 →
Security Interest
Apr 21, 2020
From: PHASEBIO PHARMACEUTICALS, INC.
To: SILICON VALLEY BANK, AS AGENT
Reel/Frame 052456/0343 →
Assignment of Assignor's Interest
Jul 22, 2020
From: SELENITY THERAPEUTICS (BERMUDA), LTD.
To: PHASEBIO PHARMACEUTICALS, INC.
Reel/Frame 053280/0207 →
Patent and Trademark Security Agreement
Nov 12, 2020
From: PHASEBIO PHARMACEUTICALS, INC.
To: SFJ PHARMACEUTICALS X, LTD.
Reel/Frame 054401/0188 →
Assignment of Assignor's Interest
Jul 8, 2021
From: SPARKS, STEVEN; YATES, CHRISTOPHER M.
To: SELENITY THERAPEUTICS, LLC
Reel/Frame 056794/0876 →